PIP-MMAE / TwoStep Therapeutics - LARVOL DELTA

TwoStep Therapeutics to Present at the 2025 SITC Annual Meeting (Businesswire)

Preclinical • Solid Tumor

TwoStep Therapeutics Unveils Its Lead Tumor-Targeted Drug Conjugate and New Radiopharmaceutical Program at Debut Scientific Presentation (Businesswire) - "TwoStep Therapeutics...is pleased to announce its debut public scientific presentation on March 27, 2025, at the 4th Novel Conjugates Summit taking place in Boston, Massachusetts. This presentation will highlight the outstanding preclinical efficacy and safety of its lead tumor-targeted drug conjugate program, along with a first look at their new radiopharmaceutical program."

New molecule • Preclinical • Solid Tumor